RxDoctor Payments DataLook up a doctor →

David Arnopole

Family · Medford, ORNPI 1720647225

Payments from drug & device makers

$38,264in general payments, 2019–2025

Across 1,146 payments — averaging $33.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • TG Therapeutics, Inc.$9K
  • Biogen$3K
  • AbbVie$3K
  • EMD Serono, Inc.$2K
  • UCB, Inc.$1K
  • AstraZeneca$1K
  • plus $18K from 54 others

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
TG Therapeutics, Inc.30$9,286
Biogen125$2,826
AbbVie196$2,793
EMD Serono, Inc.76$2,346
UCB, Inc.40$1,273
AstraZeneca(2 entities)30$1,260
Livanova USA, Inc.7$1,155
Eisai Inc.42$1,105
Merz Pharmaceuticals, LLC36$988
Novartis52$977
Teva Pharmaceuticals USA, Inc.42$964
Argenx US, Inc.27$926
Pfizer36$793
Medtronic6$790
Nevro Corp.18$701
Acadia Pharmaceuticals Inc24$694
Lundbeck LLC23$668
Neurocrine Biosciences, Inc.12$559
Genentech USA, Inc.20$535
Catalyst Pharmaceuticals, Inc.17$449
Impel Pharmaceuticals Inc.33$445
Neurelis, Inc.31$442
SK Life Science, Inc.20$441
Biohaven Pharmaceutical Holding Company Ltd.21$431
Jazz Pharmaceuticals Inc.9$413
Otsuka America Pharmaceutical, Inc.15$413
Sanofi15$387
Alnylam Pharmaceuticals Inc.5$326
Lilly USA, LLC19$310
Amgen(2 entities)8$284
Johnson & Johnson(2 entities)5$274
Abbott4$255
Boston Scientific5$242
Genentech, Inc.2$190
MDD US Operations, LLC10$185
Kyowa Kirin, Inc.9$174
Scilex Pharmaceuticals Inc.8$165
Vanda Pharmaceuticals Inc.3$158
Ipsen Biopharmaceuticals, Inc6$152
Banner Life Sciences, LLC8$138
Silk Road Medical, Inc.1$135
Acorda Therapeutics, Inc7$121
Globus Medical2$107
Amarin Pharma, Inc.1$96
Harmony Biosciences LLC1$95
Octapharma USA, Inc.4$87
Sunovion Pharmaceuticals Inc.4$72
Sandoz3$66
Tanabe Pharma America, Inc.4$64
Takeda Pharmaceuticals U.S.A., Inc.2$52
Axsome Therapeutics, Inc.2$49
Upsher-smith Laboratories LLC3$48
Grifols USA, LLC2$42
Sumitomo Pharma America, Inc.2$41
Supernus Pharmaceuticals, Inc.2$40
Amneal Pharmaceuticals LLC2$34
Mallinckrodt Hospital Products Inc.1$30
ANI Pharmaceuticals, Inc.1$26
CSL Behring1$26
Averitas Pharma Inc.1$26

How this compares

$38,264 in reported general payments places this provider in the 95th percentile of 1,130 family providers in Oregon.

See all family providers in Oregon →

Medicare billing

Part B allowed, 2024
$130,668
Medicare patients
626
Services billed
1,499

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Medford

See the full list for Oregon →

Where these figures come from

Is this you, or does something look wrong? →